Alembic Pharmaceuticals Limited has appointed Isha Lamba as Head – Investor Relations & Corporate Development, strengthening its leadership team as the company continues to focus on strategic growth, stakeholder engagement, and long-term value creation.

With more than 13 years of experience across investor relations, mergers and acquisitions, corporate strategy, capital markets, and stakeholder management, Isha has built a strong track record of supporting business growth and strengthening investor confidence across leading consumer and healthcare organizations.

Prior to joining Alembic Pharmaceuticals, she served as Head – Investor Relations and M&A at Dabur India Limited, where she played a key role in managing investor communications, evaluating strategic opportunities, and supporting corporate growth initiatives. Earlier, she held the position of DGM – M&A and Investor Relations at Godrej Consumer Products Limited, contributing to strategic transactions, business development initiatives, and shareholder engagement programs.

CXOTechBOT congratulates Isha Lamba on her appointment and wishes her continued success in driving strategic growth and stakeholder value creation at Alembic Pharmaceuticals.